A treasure trove of genetic data may hold the key to a revolution in drug development, but it offers no clues for building a ...

Liam Payne's ex-fiancee reportedly sent him a cease-and-desist letter a week before his death. The details of the legal ...

President-elect Donald Trump is making Cabinet picks and throwing around names like Elon Musk and Robert F. Kennedy Jr.

The company posted an earnings per share loss of $0.25. Development progress reported for key drugs, including brepocitinib ...

While A.I. promises breakthroughs, industry leaders warn that transparency and patient safety must remain front and center.

The genetics company is closing a unit that was once seen as core to its future.

The company said it plans to wind down ongoing clinical trials “as quickly as practical” — and that it was currently ...

GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...

Google DeepMind releases AlphaFold 3's source code to academics, marking a significant advance in AI-powered molecular biology and drug discovery, while balancing open science with commercial ...

In drug discovery, targeted protein degradation is a method that selectively eliminates disease-causing proteins. A ...